Nectar Lifesciences Ltd. - Research Center
532649 NECLIFE Group (B) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | 1,524.61 | 1,668.26 | 1,542.90 | 2,363.16 | 2,785.01 |
| Operating profit | 55.66 | 158.84 | 110.23 | 218.33 | 263.99 |
| Interest | 79.48 | 78.81 | 112.03 | 125.82 | 148.13 |
| Gross profit | 18.43 | 91.32 | 0.92 | 96.51 | 121.81 |
| EPS (Rs) | -1.00 | 1.13 | -3.26 | 1.34 | 2.11 |
Annual
results in details
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Other income | 42.24 | 11.29 | 2.72 | 4.01 | 5.96 |
| Stock adjustment | -41.64 | 14.97 | 102.80 | -5.25 | -46.99 |
| Raw material | 1,200.84 | 1,206.88 | 1,028.40 | 1,834.03 | 2,225.32 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 77.78 | 74.55 | 73.37 | 81.00 | 79.90 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 231.97 | 213.02 | 228.10 | 235.05 | 262.80 |
| Provisions made | - | - | - | - | - |
| Depreciation | 59.12 | 56.97 | 60.25 | 60.77 | 63.26 |
| Taxation | -18.24 | 9.03 | -11.50 | 5.68 | 11.22 |
| Net profit / loss | -22.46 | 25.32 | -73.15 | 30.06 | 47.33 |
| Extra ordinary item | - | - | -25.31 | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 22.43 | 22.43 | 22.43 | 22.43 | 22.43 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 3.65 | 9.52 | 7.14 | 9.24 | 9.48 |
| GPM (%) | 1.18 | 5.44 | .06 | 4.08 | 4.36 |
| NPM (%) | -1.43 | 1.51 | -4.73 | 1.27 | 1.70 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis